摩根大通在康寧發布第二季度財報前將其列入“負面催化劑觀察”名單,原因并非業績表現,而是其估值過高。該行對康寧維持“中性”評級,目標價為200美元。
特別聲明:以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布,本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.